Examkin

Question

Difficulty: MediumInfectious Diseases

A 62-year-old man receiving home total parenteral nutrition for short bowel syndrome is admitted to the hospital with a new-onset fever of 39.2°C (102.6°F) and rigors. His symptoms began shortly after flushing his tunneled central venous catheter at home. His blood pressure is 110/70 mm Hg, heart rate is 105/min, and respiratory rate is 18/min. Physical examination reveals a clean, intact catheter exit site with no erythema or purulence. He has no known drug allergies. The physician suspects a catheter-related bloodstream infection (CRBSI) and formulates a management plan.

Arrange the following clinical interventions in the most appropriate chronological order from the time of patient presentation to the implementation of final definitive therapy.

  1. 1Obtain paired blood cultures from a peripheral vein and the central venous catheter
  2. 2Initiate empiric intravenous antibiotic therapy with vancomycin and cefepime
  3. 3Remove the central venous catheter upon initial identification of Staphylococcus aureus
  4. 4Perform an echocardiogram to evaluate for cardiac vegetations
  5. 5De-escalate antimicrobial therapy to intravenous cefazolin based on final susceptibility results

Answer

The correct chronological management sequence is: 1) Obtain paired blood cultures, 2) Initiate empiric intravenous antibiotics, 3) Remove the central venous catheter, 4) Perform an echocardiogram, and 5) De-escalate to targeted intravenous cefazolin.
The correct sequence mirrors the definitive standard of care for severe healthcare-associated infections. Diagnostics (paired cultures) must universally precede therapeutics (empiric antibiotics). Once the pathogen is identified as S. aureus, source control (catheter removal) becomes the immediate priority. Because S. aureus bacteremia carries a high risk of complicated infection, an echocardiogram is subsequently mandated. Finally, antimicrobial stewardship principles dictate de-escalation from broad-spectrum empiric coverage to definitive targeted therapy (cefazolin for MSSA) once final susceptibilities are available.

Step-by-Step Solution

1
Obtain paired blood cultures from a peripheral vein and the central venous catheter
Pathogen isolation and differential time to positivity calculation.
Blood cultures must be obtained prior to the administration of any antibiotics to ensure accurate identification of the causative organism.
2
Initiate empiric intravenous antibiotic therapy with vancomycin and cefepime
Broad-spectrum coverage of common healthcare-associated pathogens.
Patients with suspected CRBSI require prompt empiric coverage for MRSA and resistant gram-negative organisms to prevent sepsis progression.
3
Remove the central venous catheter upon initial identification of Staphylococcus aureus
Immediate source control.
Unlike coagulase-negative staphylococci, S. aureus CRBSI cannot be safely treated with catheter retention (salvage therapy) due to a high risk of failure and metastatic seeding.
4
Perform an echocardiogram to evaluate for cardiac vegetations
Evaluation for infective endocarditis.
Current guidelines mandate echocardiography for all adult patients with S. aureus bacteremia to rule out endocardial involvement.
5
De-escalate antimicrobial therapy to intravenous cefazolin based on final susceptibility results
Implementation of definitive, targeted therapy.
Once MSSA is confirmed, shifting from vancomycin to an anti-staphylococcal beta-lactam (e.g., cefazolin) is required for optimal bactericidal efficacy and improved survival.

Key Concept

The management of Catheter-Related Bloodstream Infection (CRBSI) and Staphylococcus aureus bacteremia strictly follows a sequence of: pre-antibiotic paired cultures, broad-spectrum empiric therapy, mandatory catheter removal for high-risk pathogens, echocardiographic screening for endocarditis, and ultimate antibiotic de-escalation.
Rate this question

Topics

Infectious Diseases

More questions from this topic